Nathalie McKenzie, MD
Basic profileNathalie McKenzie is an Oncology physician affiliated with AdventHealth Orlando. OpenAlex indexes 61 publications with 2,878 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20258 payments$12,759
- PFIZER INC.Program year20255 payments$11,380
- GlaxoSmithKline, LLC.Program year20252 payments$4,600
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
48.1%Atypical Antipsychotic19.5%Olanzapine100%Part D≥18 patientsPhenothiazine13.9%Prochlorperazine Maleate100%Part D≥32 patients+ 2 more classes in this area
Metabolism & gastrointestinal
16%Serotonin-3 Receptor Antagonist16%Ondansetron Hcl100%Part D≥34 patientsCardiovascular
12.5%Antiarrhythmic12.5%Lidocaine-Prilocaine100%Part D≥28 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Recurrence and survival in high-intermediate risk endometrial cancers with isolated tumor cell lymph node metastasis
Gynecologic Oncology Reports
2025 - Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer
International Journal of Gynecological Cancer
2024 - Working towards health: A model of cervical cancer screening and treatment for factory employees in Haiti
International Journal of Gynecology & Obstetrics
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Lawrence Karsh, MD
AdventHealth Orlando
George Monir, MD
AdventHealth Orlando
Naushad Shaik, MD
AdventHealth Orlando
Rajesh Sehgal, MD
AdventHealth Orlando
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”